Methotrexate Completed Phase 1 Trials for Leukemia Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02270788Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies